Sarah B. Noonberg, Chief Medical Officer at Prothena, holds ― shares in Prothena (Ticker: PRTA), holds 0.00 shares in Protagonist Therapeutics (Ticker: PTGX), holds ― shares in Neurogene (Ticker: NGNE). Most recently, Sarah B. Noonberg ― shares of Prothena on ― for an estimated value of ―.